🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, ...
Status
Completed
Location
Saint Claraspital AG
Start Date
2010-01
Trial ID
NCT01057342
Treatments Being Tested
The purpose of this study is to explore the safety and activity of docetaxe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01071928
The purpose of this trial is to confirm a safe dose of AS1404, to be given ...
Status
Completed
Location
Central Hematology Oncology Medical Group Inc
Start Date
2005-05
Trial ID
NCT00111618
Treatments Being Tested
This was a phase I study aimed at identifying safe doses of DMXAA (now know...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00856336
Treatments Being Tested
The purpose of this study is to determine if adding ASA404 to docetaxel che...
Status
Terminated
Location
Oncology Specialist, P.c.
Start Date
2008-12
Trial ID
NCT00738387
This trial is designed to study the drug-drug interaction between ASA404 an...
Status
Terminated
Location
Univ. of Indiana School of Medicine/Simon Cancer Center
Start Date
2009-08
Trial ID
NCT01299415
Treatments Being Tested
This study will assess the tolerability of combination therapy with ASA404 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-03
Trial ID
NCT01285453
Treatments Being Tested
The purpose of this study is to determine if adding ASA404 to standard chem...
Status
Terminated
Location
University of South Alabama/Mitchell Cancer Institute
Start Date
2008-04
Trial ID
NCT00662597
Treatments Being Tested
The purpose of this study is to evaluate the potential inhibitory effects o...
Status
Terminated
Location
The University of Texas Science Center at Houston
Start Date
2010-02
Trial ID
NCT01290380
Treatments Being Tested
This study is designed to characterize the absorption, distribution, metabo...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2008-12
Trial ID
NCT01299701
Treatments Being Tested